Gut Health, IBS & Digestive Disorders

About This Condition

Irritable bowel syndrome (IBS) affects 10–15% of the global population and is the second most common cause of missed work after the common cold. It presents with a combination of abdominal pain, bloating, constipation, diarrhea, or mixed patterns — and is routinely dismissed as a functional or psychosomatic condition. In reality, IBS and related functional GI disorders frequently have identifiable drivers: small intestinal bacterial overgrowth (SIBO), gut dysbiosis, intestinal permeability, visceral hypersensitivity driven by prior gut infections (post-infectious IBS), food intolerances (FODMAP, histamine, gluten-adjacent), and bidirectional gut-brain axis dysfunction.

Our Approach

We take a structured investigative approach. When clinically indicated, we order GI-MAP comprehensive stool analysis (assessing pathogen load, commensal bacteria balance, inflammation markers, and digestive enzyme adequacy), hydrogen/methane breath testing for SIBO, and assess intestinal permeability markers. We use the low-FODMAP protocol as both a diagnostic tool and therapeutic intervention, with structured reintroduction to identify specific triggers. When SIBO is confirmed, we implement rifaximin-based or elemental diet eradication protocols with prokinetic follow-through to prevent recurrence. We coordinate with GI for colonoscopy or upper endoscopy when red flags are present. Our goal is to identify and remove the driver — not prescribe antispasmodics indefinitely.